305 related articles for article (PubMed ID: 18416221)
1. Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery.
Sirvinskas E; Veikutiene A; Benetis R; Grybauskas P; Andrejaitiene J; Veikutis V; Surkus J
Perfusion; 2007 Sep; 22(5):345-52. PubMed ID: 18416221
[TBL] [Abstract][Full Text] [Related]
2. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response.
Westerberg M; Bengtsson A; Jeppsson A
Ann Thorac Surg; 2004 Jul; 78(1):54-9. PubMed ID: 15223402
[TBL] [Abstract][Full Text] [Related]
3. [Autotransfusion after cardiac surgery. Hematological, biochemical and immunological properties of shed mediastinal blood].
Salas Millán J; de Vega N; Carmona Aurioles J; Negri Arjona S; García-Vallejo J; Muñoz Gómez M
Rev Esp Anestesiol Reanim; 2001 Mar; 48(3):122-30. PubMed ID: 11333796
[TBL] [Abstract][Full Text] [Related]
4. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
[TBL] [Abstract][Full Text] [Related]
5. Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery.
Sirvinskas E; Lenkutis T; Raliene L; Veikutiene A; Vaskelyte J; Marchertiene I
Perfusion; 2005 Mar; 20(2):71-5. PubMed ID: 15918443
[TBL] [Abstract][Full Text] [Related]
6. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
[TBL] [Abstract][Full Text] [Related]
7. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations.
Aouifi A; Piriou V; Blanc P; Bouvier H; Bastien O; Chiari P; Rousson R; Evans R; Lehot JJ
Br J Anaesth; 1999 Oct; 83(4):602-7. PubMed ID: 10673877
[TBL] [Abstract][Full Text] [Related]
8. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study.
So-Osman C; Nelissen RG; Eikenboom HC; Brand A
Transfus Med; 2006 Oct; 16(5):321-8. PubMed ID: 16999754
[TBL] [Abstract][Full Text] [Related]
9. [Autotransfusion of red blood cell from cardiopulmonary bypass circuit blood after cardiac surgery].
Lenkutis T; Veikutiene A; Raliene L; Surkus J
Medicina (Kaunas); 2002; 38 Suppl 2():213-6. PubMed ID: 12560664
[TBL] [Abstract][Full Text] [Related]
10. The value of procalcitonin as an infection marker in cardiac surgery.
Baykut D; Schulte-Herbrüggen J; Krian A
Eur J Med Res; 2000 Dec; 5(12):530-6. PubMed ID: 11147997
[TBL] [Abstract][Full Text] [Related]
11. Effects of shed mediastinal blood on cardiovascular and pulmonary function: a randomized, double-blind study.
Boodhwani M; Nathan HJ; Mesana TG; Rubens FD;
Ann Thorac Surg; 2008 Oct; 86(4):1167-73. PubMed ID: 18805154
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
13. [Can procalcitonin be used for the diagnosis and follow-up of postoperative complications after fracture surgery?].
Yasmin D; Bulut G; Yildiz M
Acta Orthop Traumatol Turc; 2006; 40(1):15-21. PubMed ID: 16648673
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).
Loebe M; Locziewski S; Brunkhorst FM; Harke C; Hetzer R
Intensive Care Med; 2000 Mar; 26 Suppl 2():S193-8. PubMed ID: 18470719
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study.
Vonk AB; Meesters MI; Garnier RP; Romijn JW; van Barneveld LJ; Heymans MW; Jansen EK; Boer C
Transfusion; 2013 Nov; 53(11):2782-9. PubMed ID: 23445352
[TBL] [Abstract][Full Text] [Related]
16. [Kinetics, diagnostic and prognostic value of procalcitonin after cardiac surgery].
Kallel S; Abid M; Jarraya A; Abdenadher M; Mnif E; Frikha I; Ayadi F; Karoui A
Ann Biol Clin (Paris); 2012 Oct; 70(5):567-80. PubMed ID: 23047903
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients.
Arkader R; Troster EJ; Abellan DM; Lopes MR; Júnior RR; Carcillo JA; Okay TS
J Cardiothorac Vasc Anesth; 2004 Apr; 18(2):160-5. PubMed ID: 15073705
[TBL] [Abstract][Full Text] [Related]
18. Effect of priming solution and ultrafiltration on post-operative bleeding and blood transfusion in cardiac surgery. Randomized controlled trial.
Olmos Rodríguez M; Ballester Hernández JA; Arteta Bárcenas MT; Rodríguez Cerezo A; Vidarte Ortiz de Artiñano MA; Veiga Alameda C
Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):81-9. PubMed ID: 25048999
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin, neopterin and C-reactive protein after pediatric cardiac surgery with cardiopulmonary bypass.
Skrak P; Kovacikova L; Kunovsky P
Bratisl Lek Listy; 2007; 108(12):501-5. PubMed ID: 18309639
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery.
Macrina F; Tritapepe L; Pompei F; Sciangula A; Evangelista E; Toscano F; Criniti A; Brancaccio G; Puddu PE
Perfusion; 2005 May; 20(3):169-75. PubMed ID: 16038389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
